|
1
|
Levey AS, Eckardt KU, Tsukamoto Y, et al:
Definition and classification of chronic kidney disease: a position
statement from Kidney Disease: Improving Global Outcomes (KDIGO).
Kidney Int. 67:2089–2100. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jungers P: Screening for renal
insufficiency: is it worth while? is it feasible? Nephrol Dial
Transplant. 14:2082–2084. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Akiba T, Nakai S, Shinzato T, et al: Why
has the gross mortality of dialysis patients increased in Japan?
Kidney Int. 57:S60–S65. 2000. View Article : Google Scholar
|
|
4
|
Weiner DE, Tighiouart H, Amin MG, et al:
Chronic kidney disease as a risk factor for cardiovascular disease
and all-cause mortality: a pooled analysis of community-based
studies. J Am Soc Nephrol. 15:1307–1315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jafar TH, Stark PC, Schmid CH, et al:
Progression of chronic kidney disease: the role of blood pressure
control, proteinuria, and angiotensin-converting enzyme inhibition:
a patient-level meta-analysis. Ann Intern Med. 139:244–252. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Iseki K, Ikemiya Y, Iseki C and Takishita
S: Proteinuria and the risk of developing end-stage renal disease.
Kidney Int. 63:1468–1474. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Imai E, Horio M, Iseki K, et al:
Prevalence of chronic kidney disease (CKD) in the Japanese general
population predicted by the MDRD equation modified by a Japanese
coefficient. Clin Exp Nephrol. 11:156–163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Coresh J, Astor BC, Greene T, Eknoyan G
and Levey AS: Prevalence of chronic kidney disease and decreased
kidney function in the adult US population: Third National Health
and Nutrition Examination Survey. Am J Kidn Dis. 41:1–12. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tozawa M, Iseki K, Iseki C, Kinjo K,
Ikemiya Y and Takishita S: Blood pressure predicts risk of
developing end-stage renal disease in men and women. Hypertension.
41:1341–1345. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Feld LG, Van Liew JB, Galaske RG and
Boylan JW: Selectivity of renal injury and proteinuria in the
spontaneously hypertensive rat. Kidney Int. 12:332–343. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Levine DZ: Can rodent models of diabetic
kidney disease clarify the significance of early hyperfiltration?:
recognizing clinical and experimental uncertainties. Clin Sci
(Lond). 114:109–118. 2008. View Article : Google Scholar
|
|
12
|
Yamagata K, Ishida K, Sairenchi T, et al:
Risk factors for chronic kidney disease in a community-based
population: a 10-year follow-up study. Kidney Int. 71:159–166.
2007.PubMed/NCBI
|
|
13
|
Fukamizu A, Sugimura K, Takimoto E, et al:
Chimeric renin-angiotensin system demonstrates sustained increase
in blood pressure of transgenic mice carrying both human renin and
human angiotensinogen genes. J Biol Chem. 268:11617–11621.
1993.
|
|
14
|
Fukamizu A, Seo MS, Hatae T, et al:
Tissue-specific expression of the human renin gene in transgenic
mice. Biochem Biophys Res Commun. 165:826–832. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takahashi S, Fukamizu A, Hasegawa T, et
al: Expression of the human angiotensinogen gene in transgenic mice
and transfected cells. Biochem Biophys Res Commun. 180:1103–1109.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kai T, Sugimura K, Shimada S, Kurooka A,
Takenaka T and Ishikawa K: Inhibitory effects of a subdepressor
dose of L-158,809, an angiotensin II type 1 receptor antagonist, on
cardiac hypertrophy and nephropathy via the activated human
renin-angiotensin system in double transgenic mice with
hyper-tension. Jpn Circ J. 62:599–603. 1998. View Article : Google Scholar
|
|
17
|
Kai T, Kino H and Ishikawa K: Role of the
renin-angiotensin system in cardiac hypertrophy and renal
glomerular sclerosis in transgenic hypertensive mice carrying both
human renin and angiotensinogen genes. Hypertens Res. 21:39–46.
1998. View Article : Google Scholar
|
|
18
|
Shimokama T, Haraoka S, Horiguchi H,
Sugiyama F, Murakami K and Watanabe T: The Tsukuba hypertensive
mouse (transgenic mouse carrying human genes for both renin and
angiotensinogen) as a model of human malignant hypertension:
development of lesions and morphometric analysis. Virchows Archiv.
432:169–175. 1998. View Article : Google Scholar
|
|
19
|
Hsu CY, Iribarren C, McCulloch CE,
Darbinian J and Go AS: Risk factors for end-stage renal disease:
25-year follow-up. Arch Inter Med. 169:342–350. 2009.PubMed/NCBI
|
|
20
|
Helal I, Fick-Brosnahan GM, Reed-Gitomer B
and Schrier RW: Glomerular hyperfiltration: definitions, mechanisms
and clinical implications. Nat Rev Nephrol. 8:293–300. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Russo LM, Sandoval RM, Campos SB,
Molitoris BA, Comper WD and Brown D: Impaired tubular uptake
explains albuminuria in early diabetic nephropathy. J Am Soc
Nephrol. 20:489–494. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Comper WD, Haraldsson B and Deen WM:
Resolved: normal glomeruli filter nephrotic levels of albumin. J Am
Soc Nephrol. 19:427–432. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Birn H and Christensen EI: Renal albumin
absorption in physiology and pathology. Kidney Int. 69:440–449.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wada T, Furuichi K, Sakai N, et al:
Up-regulation of monocyte chemoattractant protein-1 in
tubulointerstitial lesions of human diabetic nephropathy. Kidney
Int. 58:1492–1499. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Korrapati MC, Shaner BE, Neely BA, Alge
JL, Arthur JM and Schnellmann RG: Diabetes-induced renal injury in
rats is attenuated by suramin. J Pharmacol Exp Ther. 343:34–43.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eardley KS, Zehnder D, Quinkler M, et al:
The relationship between albuminuria, MCP-1//CCL2, and interstitial
macrophages in chronic kidney disease. Kidney Int. 69:1189–1197.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Taniguchi H, Kojima R, Sade H, Furuya M,
Inomata N and Ito M: Involvement of MCP-1 in tubulointerstitial
fibrosis through massive proteinuria in anti-GBM nephritis induced
in WKY rats. J Clin Immunol. 27:409–429. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hostetter TH, Olson JL, Rennke HG,
Venkatachalam MA and Brenner BM: Hyperfiltration in remnant
nephrons: a potentially adverse response to renal ablation. Am J
Physiol. 241:F85–F93. 1981.PubMed/NCBI
|
|
29
|
Kanwar YS, Danesh FR and Chugh SS:
Contribution of proteoglycans towards the integrated functions of
renal glomerular capillaries: a historical perspective. Am J
Pathol. 171:9–13. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Haraldsson B, Nyström J and Deen WM:
Properties of the glomerular barrier and mechanisms of proteinuria.
Physiol Rev. 88:451–487. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Broekhuizen LN, Lemkes BA, Mooij HL, et
al: Effect of sulodexide on endothelial glycocalyx and vascular
permeability in patients with type 2 diabetes mellitus.
Diabetologia. 53:2646–2655. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Salmon AHJ, Ferguson JK, Burford JL, et
al: Loss of the endothelial glycocalyx links albuminuria and
vascular dysfunction. J Am Soc Nephrol. 23:1339–1350. 2012.
View Article : Google Scholar : PubMed/NCBI
|
